Researchers Show How Leukemia Develops After Cancer Treatment
May 2005

JAK2 Gene Produces Too Many Blood Cells - Confirmed
May 2005

Study: Young cancer patients bounce back
February 2005

Race for the Cure: The Role of the New York Phase II Consortium
January 2005

Report: Cancer rates down, survival up
June 2004

Although Recommended, G-CSF After Marrow Transplant May Raise Graft-Versus-Host Disease Risk
March 2004

Gleevec Prolongs Life
December 2003

CR&T awards grant to Johns Hopkins group for studies of polycythemia vera
April 2003

Polycythemia Vera: Gleevec may be effective against second blood disease
January 2003

Novartis Pharmaceuticals: New drug significantly improves survival even for patients with late-stage disease
January 2003

Dr. Silver and members of CR&T medical board present findings at national hematology meeting
December 2002

Antiangiogenics May Hold Promise for Leukemia
November 2002

Erasing signs of leukemia
Drug promising, but it may not help all patients
May 2002

Leukemia and Myeloproliferative Diseases Center to Be Established with Grant from Cancer Research and Treatment Fund (Cornell University)
March 2002

Dr. Scott Wadler Named to Silver Professorship
February 2002

Gleevec: Mixed Opinions Now After Initial Enthusiasm
December 2001

Scientists Link Tumors To Bone Marrow Cells
November 2001

Dr. Silver receives Timothy Gee award
May 2001

New AmmunitionIn Cancer War Wonder drugs disarm proteins,with minimal side effects (New York Daily News)
May 20, 2001, New York

Dr. Richard Silver's speech at 2001 Hall of Fame Dinner
April 2001, New York

Dr. Coleman Receives Award from Lymphoma Organization
March 2001, New York

For additional information, please contact: